Author

Yang Chen

Institutions: Fudan University Shanghai Cancer Center, Zhejiang Provincial People's Hospital, Hangzhou Medical College

Observed institutions: Shanghai Medical College of Fudan University, Chongqing University, Shanghai Normal University, Fudan University, Fudan University Shanghai Cancer Center, Zhejiang Provincial People's Hospital, Chongqing Cancer Hospital, Hangzhou Medical College

ORCID: 0000-0003-2162-3648

Observed ORCID: 0000-0003-2162-3648

OpenAlex ID: A5034668597

Inhibition of EGFR Overcomes Acquired Lenvatinib Resistance Driven by STAT3–ABCB1 Signaling in Hepatocellular Carcinoma

2022 · Beiyuan Hu, Tiantian Zou, et al. · Cancer Research · 210

Oxygen-Independent Radiodynamic Therapy: Radiation-Boosted Chemodynamics for Reprogramming the Tumor Immune Environment and Enhancing Antitumor Immune Response

2024 · Yang Chen, Yong Deng, et al. · ACS Applied Materials & Interfaces · 95

DNASE1L3-mediated PANoptosis enhances the efficacy of combination therapy for advanced hepatocellular carcinoma

2024 · Jingchun Wang, Yu Chen, et al. · Theranostics · 36

Sophora flavescens-derived extracellular vesicles loaded with oncolytic vaccinia virus/IR1061 for NIR-II photoacoustic imaging guided multimodal treatment of diffuse large B-cell lymphoma

2025 · Lichen Ji, Jiaqing Huang, et al. · Materials Today Bio · 6

Data from Inhibition of EGFR Overcomes Acquired Lenvatinib Resistance Driven by STAT3–ABCB1 Signaling in Hepatocellular Carcinoma

2023 · Beiyuan Hu, Tiantian Zou, et al. · 1

Phase I study of hV01, a recombinant human IL-21-expressing oncolytic vaccinia virus, as monotherapy in advanced solid tumors.

2025 · Jian Zhang, Wenxing Qin, et al. · Journal of Clinical Oncology

The N6 ‐methyladenosine methylation landscape stratifies breast cancer into two subtypes with distinct immunological characteristics

2024 · Yang Chen, Yijiang Hou, et al. · Clinical and Experimental Pharmacology and Physiology

Supplementary Data from Inhibition of EGFR Overcomes Acquired Lenvatinib Resistance Driven by STAT3–ABCB1 Signaling in Hepatocellular Carcinoma

2023 · Beiyuan Hu, Tiantian Zou, et al.

Supplementary Data from Inhibition of EGFR Overcomes Acquired Lenvatinib Resistance Driven by STAT3–ABCB1 Signaling in Hepatocellular Carcinoma

2023 · Beiyuan Hu, Tiantian Zou, et al.

Data from Inhibition of EGFR Overcomes Acquired Lenvatinib Resistance Driven by STAT3–ABCB1 Signaling in Hepatocellular Carcinoma

2023 · Beiyuan Hu, Tiantian Zou, et al.

Works count: 10

Citation count: 348

H-index: 4

I10-index: 3